These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 19494241)
1. Vascular regression and survival are differentially regulated by MT1-MMP and TIMPs in the aortic ring model of angiogenesis. Aplin AC; Zhu WH; Fogel E; Nicosia RF Am J Physiol Cell Physiol; 2009 Aug; 297(2):C471-80. PubMed ID: 19494241 [TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K; Shigemasa K; Nagai N; Ohama K Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877 [TBL] [Abstract][Full Text] [Related]
3. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829 [TBL] [Abstract][Full Text] [Related]
4. Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females. Voloshenyuk TG; Gardner JD Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R683-93. PubMed ID: 20504902 [TBL] [Abstract][Full Text] [Related]
5. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545 [TBL] [Abstract][Full Text] [Related]
6. Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases. Remacle AG; Shiryaev SA; Radichev IA; Rozanov DV; Stec B; Strongin AY J Biol Chem; 2011 Jun; 286(23):21002-12. PubMed ID: 21518756 [TBL] [Abstract][Full Text] [Related]
7. The activity of a designer tissue inhibitor of metalloproteinases (TIMP)-1 against native membrane type 1 matrix metalloproteinase (MT1-MMP) in a cell-based environment. Lee MH; Atkinson S; Rapti M; Handsley M; Curry V; Edwards D; Murphy G Cancer Lett; 2010 Apr; 290(1):114-22. PubMed ID: 19815335 [TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. Davis GE; Pintar Allen KA; Salazar R; Maxwell SA J Cell Sci; 2001 Mar; 114(Pt 5):917-30. PubMed ID: 11181175 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts. Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699 [TBL] [Abstract][Full Text] [Related]
10. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms. Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849 [TBL] [Abstract][Full Text] [Related]
11. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix. Collen A; Hanemaaijer R; Lupu F; Quax PH; van Lent N; Grimbergen J; Peters E; Koolwijk P; van Hinsbergh VW Blood; 2003 Mar; 101(5):1810-7. PubMed ID: 12393408 [TBL] [Abstract][Full Text] [Related]
12. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system. Jo Y; Yeon J; Kim HJ; Lee ST Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509 [TBL] [Abstract][Full Text] [Related]
13. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). Lafleur MA; Handsley MM; Knäuper V; Murphy G; Edwards DR J Cell Sci; 2002 Sep; 115(Pt 17):3427-38. PubMed ID: 12154073 [TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization. Ma DH; Chen JK; Kim WS; Hao YX; Wu HC; Tsai RJ; Hwang DG; Zhang F Ophthalmic Res; 2001; 33(6):353-62. PubMed ID: 11721189 [TBL] [Abstract][Full Text] [Related]
15. Effect of hormone replacement therapy in matrix metalloproteinase expression and intimal hyperplasia development after vascular injury. Mountain DJ; Freeman MB; Kirkpatrick SS; Cook RB; Chalk JE; Stevens SL; Goldman MH; Grandas OH Ann Vasc Surg; 2013 Apr; 27(3):337-45. PubMed ID: 23088810 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. Muir EM; Adcock KH; Morgenstern DA; Clayton R; von Stillfried N; Rhodes K; Ellis C; Fawcett JW; Rogers JH Brain Res Mol Brain Res; 2002 Apr; 100(1-2):103-17. PubMed ID: 12008026 [TBL] [Abstract][Full Text] [Related]
17. MT1-MMP, but not secreted MMPs, influences the migration of human microvascular endothelial cells in 3-dimensional collagen gels. Koike T; Vernon RB; Hamner MA; Sadoun E; Reed MJ J Cell Biochem; 2002; 86(4):748-58. PubMed ID: 12210741 [TBL] [Abstract][Full Text] [Related]
18. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2. Nishida Y; Miyamori H; Thompson EW; Takino T; Endo Y; Sato H Cancer Res; 2008 Nov; 68(21):9096-104. PubMed ID: 18974156 [TBL] [Abstract][Full Text] [Related]
19. Targeting a Designer TIMP-1 to the Cell Surface for Effective MT1-MMP Inhibition: A Potential Role for the Prion Protein in Renal Carcinoma Therapy. Jiang B; Liu J; Lee MH Molecules; 2019 Jan; 24(2):. PubMed ID: 30641935 [TBL] [Abstract][Full Text] [Related]
20. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells. Zhong J; Gencay MM; Bubendorf L; Burgess JK; Parson H; Robinson BW; Tamm M; Black JL; Roth M J Cell Physiol; 2006 May; 207(2):540-52. PubMed ID: 16447244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]